跳至主要内容
临床试验/NCT01237028
NCT01237028已完成不适用

Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

Yonsei University7 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2011年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
168
试验地点
7
主要终点
changes in proteinuria

研究概览

简要总结

This study will help to show the efficacy of vitamin D and address the optimal strategy to minimize renal injury in IgAN patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Biopsy-proven Ig AN patients aged 20-70 years
  • Patients with residual proteinuria > 500 mg/g creatinine despite renin-angiotensin system blockade and adequate blood pressure control for more than 3 months
  • Patients who give informed consent, and 4) estimated GFR >= 30 ml/min/1.73 m2.

排除标准

  • patients < 20 years or > 70 years
  • hypersensitivity to vitamin D analogs
  • patients who need urgent dialysis
  • hypercalcemia within 3 months (uncorrected serum calcium level > 10.2 mg/dL)
  • clinical features of rapidly progressive glomerulonephritis
  • life expectancy less than 24 months
  • uncontrolled hypertension
  • decompensated liver or lung disease
  • symptomatic heart failure (NYHA class II-IV or LVEF < 40%)
  • estimated GFR < 30 ml/min/1.73 m2.

研究组 & 干预措施

oral calcitriol

Experimental

Calcio®

干预措施: Calcitriol (Drug)

结局指标

主要结局

changes in proteinuria

时间窗: random urine protein/creatinine ratio every 2month and 24hour urine protein every 6month

comparison of proteinuria amount checked by random urine protein/creatinine and 24hour urine protein

次要结局

  • changes in serum creatinine(serum creatinine every 2month)
  • changes in systolic blood pressure and diastolic pressure(check blood pressure at very first visit and every 2-month)
  • changes in serum 25(OH)2D3, 1,25(OH)2D3, parathyroid hormone(every 6month)
  • changes in serum inflammatory markers (hsCRP, IL-6)(every 6month)
  • changes in urinary biomarkers (angiotensinogen, angiotensin II, TGF-beat, IL-6, MCP-1, TNF-alpha)(every 6month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验